Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-12 Option Award | 2026-02-17 4:21 pm | N/A 2036-02-12 | TuHURA Biosciences Inc. | HURA | Tendler Craig Director | 156,240 | $0 | 308,123 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 4:19 pm | N/A 2036-02-12 | TuHURA Biosciences Inc. | HURA | Ng George K Director | 156,240 | $0 | 207,515 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 4:17 pm | N/A 2036-02-12 | TuHURA Biosciences Inc. | HURA | MANUSO JAMES S J Director | 156,240 | $0 | 215,830 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 4:16 pm | N/A 2036-02-12 | TuHURA Biosciences Inc. | HURA | List Alan Director | 156,240 | $0 | 207,515 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 4:09 pm | N/A 2036-02-12 | TuHURA Biosciences Inc. | HURA | Hoffman Robert E. Director | 156,240 | $0 | 207,515 (Direct) | View |
| 2026-01-06 Option Award | 2026-01-08 4:35 pm | N/A 2036-01-06 | TuHURA Biosciences Inc. | HURA | Dearborn Dan Chief Financial Officer | 273,696 | $0 | 273,696 (Direct) | View |
| 2026-01-06 Option Award | 2026-01-08 4:33 pm | N/A 2036-01-06 | TuHURA Biosciences Inc. | HURA | Bianco James A. Chief Executive Officer | 610,332 | $0 | 610,332 (Direct) | View |
| 2025-12-12 Option Award | 2025-12-17 06:37 am | N/A 2035-12-12 | TuHURA Biosciences Inc. | HURA | Dearborn Dan Chief Financial Officer | 1,531,367 | $0 | 1,531,367 (Direct) | View |
| 2025-12-12 Option Award | 2025-12-17 06:36 am | N/A 2035-12-12 | TuHURA Biosciences Inc. | HURA | Bianco James A. Chief Executive Officer | 3,414,891 | $0 | 3,414,891 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-19 7:13 pm | N/A 2035-03-10 | TuHURA Biosciences Inc. | HURA | Tendler Craig Director | 151,883 | $0 | 151,883 (Direct) | View |
Ownership | 2025-03-19 7:12 pm | N/A N/A | TuHURA Biosciences Inc. | HURA | Tendler Craig Director | 0 | $0 | 0 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 5:08 pm | N/A 2035-01-02 | TuHURA Biosciences Inc. | HURA | Hoffman Robert E. Director | 51,275 | $0 | 51,275 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:58 pm | N/A 2035-01-02 | TuHURA Biosciences Inc. | HURA | MANUSO JAMES S J Director | 59,590 | $0 | 59,590 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:56 pm | N/A 2035-01-02 | TuHURA Biosciences Inc. | HURA | List Alan Director | 51,275 | $0 | 51,275 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:54 pm | N/A 2035-01-02 | TuHURA Biosciences Inc. | HURA | Ng George K Director | 51,275 | $0 | 51,275 (Direct) | View |
| 2024-11-12 Option Award | 2024-11-14 4:48 pm | N/A 2034-11-12 | TuHURA Biosciences Inc. | HURA | Bianco James A. Chief Executive Officer | 1,065,990 | $0 | 1,065,990 (Direct) | View |
| 2024-11-12 Option Award | 2024-11-14 4:46 pm | N/A 2034-11-12 | TuHURA Biosciences Inc. | HURA | Dearborn Dan Chief Financial Officer | 489,848 | $0 | 489,848 (Direct) | View |
| 2024-10-18 Option Award | 2024-10-22 9:12 pm | N/A 2034-01-19 | Kintara Therapeutics Inc. | KTRA | Yamashita Dennis Chief Scientific Officer | 196,790 | $0 | 196,790 (Direct) | View |
Ownership | 2024-10-22 8:50 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Patel Vijay 10% Owner | 0 | $0 | 12,364,430 (Indirect) | View |
| 2024-10-18 Option Award | 2024-10-22 8:47 pm | 2024-10-18 2030-02-06 | Kintara Therapeutics Inc. | KTRA | Ng George K Director | 62,886 | $0 | 62,886 (Direct) | View |
Ownership | 2024-10-22 8:44 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Ng George K Director | 0 | $0 | 0 (Direct) | View |
| 2024-10-18 Option Award | 2024-10-22 8:41 pm | 2024-10-18 2033-01-16 | Kintara Therapeutics Inc. | KTRA | List Alan Director | 27,106 | $0 | 27,106 (Direct) | View |
Ownership | 2024-10-22 8:38 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | List Alan Director | 0 | $0 | 0 (Direct) | View |
| 2024-10-18 Option Award | 2024-10-22 8:36 pm | 2024-10-18 2033-01-16 | Kintara Therapeutics Inc. | KTRA | MANUSO JAMES S J Director | 27,106 | $0 | 27,106 (Direct) | View |
Ownership | 2024-10-22 8:33 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | MANUSO JAMES S J Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2024-10-22 8:13 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Yamashita Dennis Chief Scientific Officer | 0 | $0 | 0 (Direct) | View |
| 2024-10-18 Option Award | 2024-10-22 8:10 pm | 2024-10-18 2031-07-01 | Kintara Therapeutics Inc. | KTRA | Bianco James A. Chief Executive Officer | 2,943,947 | $0 | 2,943,947 (Direct) | View |
Ownership | 2024-10-22 8:07 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Bianco James A. Chief Executive Officer | 0 | $0 | 0 (Direct) | View |
| 2024-10-18 Option Award | 2024-10-22 8:01 pm | 2024-10-18 2026-01-17 | Kintara Therapeutics Inc. | KTRA | Dearborn Dan Chief Financial Officer | 417,401 | $0 | 417,401 (Direct) | View |
Ownership | 2024-10-22 7:56 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Dearborn Dan Chief Financial Officer | 0 | $0 | 0 (Direct) | View |
| 2023-08-30 Option Award | 2023-09-01 6:00 pm | N/A 2033-08-30 | Kintara Therapeutics Inc. | KTRA | Johnson Laura L. Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2023-08-30 Option Award | 2023-09-01 6:00 pm | N/A 2033-08-30 | Kintara Therapeutics Inc. | KTRA | FAVORITO TAMARA A Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2023-08-30 Option Award | 2023-09-01 6:00 pm | N/A 2033-08-30 | Kintara Therapeutics Inc. | KTRA | Hoffman Robert E. President, CEO and Interim CFO | 23,142 | $0 | 23,142 (Direct) | View |
| 2023-08-30 Option Award | 2023-09-01 6:00 pm | N/A 2033-08-30 | Kintara Therapeutics Inc. | KTRA | TOTH ROBERT JOSEPH JR Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2023-08-30 Option Award | 2023-09-01 6:00 pm | N/A 2033-08-30 | Kintara Therapeutics Inc. | KTRA | Brown Dennis M Chief Scientific Officer | 10,175 | $0 | 10,175 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 4:05 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Hoffman Robert E. President, CEO, and CFO | 59,800 | $0 | 68,902 (Direct) | View |
| 2023-01-05 Acquisition | 2023-01-06 7:26 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Brown Dennis M Chief Scientific Officer | 363 | $0 | 6,377 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-03 4:30 pm | N/A 2022-08-02 | Kintara Therapeutics Inc. | KTRA | Praill Anthony Scott Chief Financial Officer | 960,347 | $0 | 997,533 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-03 4:30 pm | N/A 2022-08-02 | Kintara Therapeutics Inc. | KTRA | Brown Dennis M Chief Scientific Officer | 960,347 | $0 | 1,020,915 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-03 4:30 pm | N/A 2022-08-02 | Kintara Therapeutics Inc. | KTRA | Hoffman Robert E. President and CEO | 1,600,779 | $0 | 1,655,779 (Direct) | View |